Coffee

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

HONG KONG,Feb. 6,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company")is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/

Coffee

Feb 7, 2025

St. Luke's Medical Center Achieves GHA Accreditation for Medical Travel Services

PALM BEACH GARDENS,Fla.,Feb. 6,2025--St. Luke\'s Medical Centerhas achieved another significant milestone,becoming the first and only hospital in the Philippines to receive accreditation from the este

Coffee

Feb 7, 2025

SK hynix Acquires 'TISAX' Certification for the First Time in the Memory Industry

- Acquires TISAX certification for domestic sites,meeting the level of information security needs of the global automotive industry

Coffee

Feb 7, 2025

Foretellix and MathWorks Partner on Innovative Toolchain to Accelerate Mazda's Next Generation AV Development

TOKYO and SUNNYVALE,Calif.,Feb. 6,2025-- Strategic technological integration between Foretellix,the leading provider of data-driven autonomy development toolchains,and MathWorks,the leading developer

Coffee

Feb 7, 2025

GCCL Applauded by Frost & Sullivan for Ensuring Consistent, Reliable Clinical Trial Data in APAC

GCCL is committed to customer success,emphasizing quality control at every stage—from analysis consulting and sample processing to data management—ensuring efficient clinical trials and research an

Coffee

Feb 7, 2025

Aker Horizons ASA: Invitation to presentation of fourth-quarter results 2024

FORNEBU,Norway,Feb. 6,2025-- Aker Horizons (OSE:AKH) will publish its financial results for the fourth quarter 2024 on Thursday 13 February 2025,at 07:00 CET. An online presentation of the results wil

Coffee

Feb 7, 2025

1 ... 80 81 82 83 84 85 86 ... 119